Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Nurmi EL"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-19 z 19
    Tytuł:
    Environmental education of Z generation students for sustainable development of rural areas (the example of the Russian-Finnish project Luga-Balt-2)
    Autorzy:
    Kartseva Alexandra
    Minin Vladislav
    Ranta-Korhonen Tuija
    Nurmi Elina
    Belyakov Valery
    Pokaż więcej
    Temat:
    Environmental sciences
    GE1-350
    Źródło:
    E3S Web of Conferences, Vol 296, p 08017 (2021)
    Opis pliku:
    electronic resource
    Relacje:
    https://www.e3s-conferences.org/articles/e3sconf/pdf/2021/72/e3sconf_esmgt2021_08017.pdf; https://doaj.org/toc/2267-1242
    Dostęp URL:
    https://doaj.org/article/e9a3ab06fd9047b4b23ff65fdb7e6ce8  Link otwiera się w nowym oknie
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    CYP2D6 genotype may moderate measures of brain structure in methamphetamine users.
    Autorzy:
    Dean AC; Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, California, USA.; Brain Research Institute, UCLA David Geffen School of Medicine, Los Angeles, California, USA.
    Nurmi EL; Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, California, USA.; Brain Research Institute, UCLA David Geffen School of Medicine, Los Angeles, California, USA.; Department of Mental Health, VA Greater Los Angeles Healthcare System, Los Angeles, California, USA.
    Morales AM; Department of Psychiatry, Oregon Health & Science University, Portland, Oregon, USA.
    Cho AK; Environmental Health Sciences, UCLA Fielding School of Public Health, Los Angeles, California, USA.
    Seaman LC; Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, California, USA.
    London ED; Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, California, USA.; Brain Research Institute, UCLA David Geffen School of Medicine, Los Angeles, California, USA.; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, Los Angeles, California, USA.
    Pokaż więcej
    Źródło:
    Addiction biology [Addict Biol] 2021 May; Vol. 26 (3), pp. e12950. Date of Electronic Publication: 2020 Aug 06.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Amphetamine-Related Disorders/*genetics
    Brain/*pathology
    Central Nervous System Stimulants/*adverse effects
    Cytochrome P-450 CYP2D6/*genetics
    Methamphetamine/*adverse effects
    Adolescent ; Adult ; Amphetamine-Related Disorders/pathology ; Amphetamine-Related Disorders/psychology ; Brain/diagnostic imaging ; Case-Control Studies ; Central Nervous System Stimulants/metabolism ; Cognition/drug effects ; Female ; Genotype ; Humans ; Magnetic Resonance Imaging ; Male ; Memory ; Methamphetamine/metabolism ; Middle Aged ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Panacea, placebo or poison? Genetically guided treatment for depression.
    Autorzy:
    Nurmi EL; Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, Los Angeles, CA, USA.
    Pokaż więcej
    Źródło:
    Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) [Braz J Psychiatry] 2020 Apr; Vol. 42 (2), pp. 118-119. Date of Electronic Publication: 2020 Apr 06.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Antidepressive Agents/*pharmacology
    Depressive Disorder/*drug therapy
    Depressive Disorder/*genetics
    Humans ; Pharmacogenomic Testing/standards ; Placebo Effect ; Practice Guidelines as Topic ; United States ; United States Food and Drug Administration
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    No effect of attentional bias modification training in methamphetamine users receiving residential treatment.
    Autorzy:
    Dean AC; Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, CA, 90024, USA.; Brain Research Institute, David Geffen School of Medicine, Los Angeles, CA, 90024, USA.
    Nurmi EL; Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, CA, 90024, USA.
    Moeller SJ; Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, NY, 11794, USA.
    Amir N; Department of Psychology, San Diego State University, San Diego, CA, 92120, USA.
    Rozenman M; Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, CA, 90024, USA.
    Ghahremani DG; Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, CA, 90024, USA.
    Johnson M; Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, CA, 90024, USA.
    Berberyan R; Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, CA, 90024, USA.
    Hellemann G; Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, CA, 90024, USA.
    Zhang Z; Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, CA, 90024, USA.
    London ED; Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, CA, 90024, USA. .; Brain Research Institute, David Geffen School of Medicine, Los Angeles, CA, 90024, USA. .; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, Los Angeles, CA, 90024, USA. .
    Pokaż więcej
    Źródło:
    Psychopharmacology [Psychopharmacology (Berl)] 2019 Feb; Vol. 236 (2), pp. 709-721. Date of Electronic Publication: 2018 Nov 10.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Amphetamine-Related Disorders/*diagnostic imaging
    Amphetamine-Related Disorders/*psychology
    Attentional Bias/*physiology
    Central Nervous System Stimulants/*adverse effects
    Methamphetamine/*adverse effects
    Residential Treatment/*trends
    Adult ; Attentional Bias/drug effects ; Craving/drug effects ; Craving/physiology ; Female ; Humans ; Magnetic Resonance Imaging/methods ; Magnetic Resonance Imaging/trends ; Male ; Photic Stimulation/methods ; Reproducibility of Results ; Residential Treatment/methods ; Self Report
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Effect of overnight smoking abstinence on a marker for microglial activation: a [ C]DAA1106 positron emission tomography study.
    Autorzy:
    Brody AL; Department of Psychiatry, University of California, San Diego/VA San Diego Healthcare System, San Diego, CA, USA. .; Department of Research, VA San Diego Healthcare System, 3350 La Jolla Village Drive (116A), San Diego, CA, 92161, USA. .
    Gehlbach D; Department of Psychiatry, University of California, San Diego/VA San Diego Healthcare System, San Diego, CA, USA.; Department of Research, VA San Diego Healthcare System, 3350 La Jolla Village Drive (116A), San Diego, CA, 92161, USA.
    Garcia LY; Department of Psychiatry, University of California, San Diego/VA San Diego Healthcare System, San Diego, CA, USA.; Department of Research, VA San Diego Healthcare System, 3350 La Jolla Village Drive (116A), San Diego, CA, 92161, USA.
    Enoki R; Department of Psychiatry, University of California, San Diego/VA San Diego Healthcare System, San Diego, CA, USA.; Department of Research, VA San Diego Healthcare System, 3350 La Jolla Village Drive (116A), San Diego, CA, 92161, USA.
    Hoh C; Department of Radiology, University of California, San Diego, San Diego, CA, USA.
    Vera D; Department of Radiology, University of California, San Diego, San Diego, CA, USA.
    Kotta KK; Department of Radiology, University of California, San Diego, San Diego, CA, USA.
    London ED; Department of Psychiatry, University of California at Los Angeles, Los Angeles, CA, USA.; Department of Research, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
    Okita K; Department of Psychiatry, University of California at Los Angeles, Los Angeles, CA, USA.; Department of Research, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.; Department of Clinical Neuroimaging, Integrative Brain Imaging Center, National Center of Neurology and Psychiatry, Tokyo, Japan.
    Nurmi EL; Department of Psychiatry, University of California at Los Angeles, Los Angeles, CA, USA.
    Seaman LC; Department of Psychiatry, University of California at Los Angeles, Los Angeles, CA, USA.
    Mandelkern MA; Nuclear Medicine Service, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
    Pokaż więcej
    Źródło:
    Psychopharmacology [Psychopharmacology (Berl)] 2018 Dec; Vol. 235 (12), pp. 3525-3534. Date of Electronic Publication: 2018 Oct 20.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Acetamides/*metabolism
    Brain/*metabolism
    Carbon Radioisotopes/*metabolism
    Microglia/*metabolism
    Phenyl Ethers/*metabolism
    Positron-Emission Tomography/*methods
    Smoking/*metabolism
    Adult ; Biomarkers/metabolism ; Brain/diagnostic imaging ; Female ; Humans ; Male ; Middle Aged ; Receptors, GABA/metabolism ; Smoking Cessation ; Time Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS.
    Autorzy:
    Mattheisen M; 1] Department of Biomedicine and Center for Integrated Sequencing (iSEQ), Aarhus University, Aarhus, Denmark [2] Department of Biostatistics, Harvard School of Public Health, Boston, MA, USA [3] Department of Genomic Mathematics, University of Bonn, Bonn, Germany.
    Samuels JF; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
    Wang Y; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
    Greenberg BD; Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI, USA.
    Fyer AJ; New York State Psychiatric Institute, College of Physicians and Surgeons at Columbia University, New York, NY, USA.
    McCracken JT; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles School of Medicine, Los Angeles, CA, USA.
    Geller DA; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
    Murphy DL; Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD, USA.
    Knowles JA; Department of Psychiatry and Behavioral SciencesKeck School of Medicine at the University of Southern California, Los Angeles, CA, USA.
    Grados MA; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
    Riddle MA; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
    Rasmussen SA; Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI, USA.
    McLaughlin NC; Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI, USA.
    Nurmi EL; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles School of Medicine, Los Angeles, CA, USA.
    Askland KD; Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI, USA.
    Qin HD; Division of Intramural Research Program, National Institute of Mental Health, Unit of Statistical Genomics, Intramural Research Program, Bethesda, MD, USA.
    Cullen BA; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
    Piacentini J; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles School of Medicine, Los Angeles, CA, USA.
    Pauls DL; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
    Bienvenu OJ; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
    Stewart SE; 1] Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA [2] Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.
    Liang KY; Department of Mental Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
    Goes FS; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
    Maher B; Department of Mental Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
    Pulver AE; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
    Shugart YY; Division of Intramural Research Program, National Institute of Mental Health, Unit of Statistical Genomics, Intramural Research Program, Bethesda, MD, USA.
    Valle D; Institute of Human Genetics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
    Lange C; 1] Department of Biostatistics, Harvard School of Public Health, Boston, MA, USA [2] Department of Genomic Mathematics, University of Bonn, Bonn, Germany.
    Nestadt G; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
    Pokaż więcej
    Źródło:
    Molecular psychiatry [Mol Psychiatry] 2015 Mar; Vol. 20 (3), pp. 337-44. Date of Electronic Publication: 2014 May 13.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
    MeSH Terms:
    Family Health*
    Genetic Predisposition to Disease/*genetics
    Obsessive-Compulsive Disorder/*genetics
    Adult ; Chromosomes, Human, Pair 9/genetics ; Cooperative Behavior ; Female ; Follow-Up Studies ; Gene Expression Profiling ; Genome-Wide Association Study ; Genotype ; Humans ; Male ; Oligonucleotide Array Sequence Analysis ; Polymorphism, Single Nucleotide ; Receptor-Like Protein Tyrosine Phosphatases, Class 2/genetics ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Thalamic glutamate decreases with cigarette smoking.
    Autorzy:
    O'Neill J; Division of Child & Adolescent Psychiatry, UCLA Semel Institute for Neuroscience, 760 Westwood Plaza, Box 175919, Los Angeles, CA, 90024-1759, USA, .
    Tobias MC
    Hudkins M
    Oh EY
    Hellemann GS
    Nurmi EL
    London ED
    Pokaż więcej
    Źródło:
    Psychopharmacology [Psychopharmacology (Berl)] 2014 Jul; Vol. 231 (13), pp. 2717-24. Date of Electronic Publication: 2014 Feb 18.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Glutamic Acid/*metabolism
    Receptors, Nicotinic/*metabolism
    Smoking/*metabolism
    Thalamus/*metabolism
    Adult ; Case-Control Studies ; Female ; Humans ; Male ; Proton Magnetic Resonance Spectroscopy/methods ; Time Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders.
    Autorzy:
    McCracken JT; Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, Semel Institute for Neuroscience, Los Angeles, CA, USA.
    Badashova KK; Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, Semel Institute for Neuroscience, Los Angeles, CA, USA.
    Posey DJ; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA.
    Aman MG; Departments of Psychiatry and Psychology, The Nisonger Center UCEDD, Ohio State University, Columbus, OH, USA.
    Scahill L; Child Study Center, Yale University, New Haven, CT, USA.
    Tierney E; Department of Psychiatry, Kennedy Krieger Institute, Johns Hopkins University, Baltimore, MD, USA.
    Arnold LE; Departments of Psychiatry and Psychology, The Nisonger Center UCEDD, Ohio State University, Columbus, OH, USA.
    Vitiello B; National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
    Whelan F; Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, Semel Institute for Neuroscience, Los Angeles, CA, USA.
    Chuang SZ; Department of Psychiatry, Columbia University, New York, NY, USA.
    Davies M; Department of Psychiatry, Columbia University, New York, NY, USA.
    Shah B; Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, Semel Institute for Neuroscience, Los Angeles, CA, USA.
    McDougle CJ; Department of Psychiatry, Lurie Autism Center, Massachusetts General Hospital, Boston, MA, USA.
    Nurmi EL; Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, Semel Institute for Neuroscience, Los Angeles, CA, USA.
    Pokaż więcej
    Źródło:
    The pharmacogenomics journal [Pharmacogenomics J] 2014 Jun; Vol. 14 (3), pp. 295-302. Date of Electronic Publication: 2013 Jul 16.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Attention Deficit Disorder with Hyperactivity/*drug therapy
    Attention Deficit Disorder with Hyperactivity/*genetics
    Biogenic Monoamines/*metabolism
    Central Nervous System Stimulants/*therapeutic use
    Child Development Disorders, Pervasive/*genetics
    Methylphenidate/*therapeutic use
    Attention Deficit Disorder with Hyperactivity/complications ; Child ; Child Development Disorders, Pervasive/complications ; Humans
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-19 z 19

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies